These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 23704125)
1. Effectiveness of ampicillin plus ceftriaxone compared to ampicillin plus gentamicin for treating Enterococcus faecalis infective endocarditis: a noninferiority question not yet properly investigated. Solla DJ Clin Infect Dis; 2013 Sep; 57(5):768. PubMed ID: 23704125 [No Abstract] [Full Text] [Related]
2. Ampicillin plus ceftriaxone is as effective as ampicillin plus gentamicin for treating enterococcus faecalis infective endocarditis. Fernández-Hidalgo N; Almirante B; Gavaldà J; Gurgui M; Peña C; de Alarcón A; Ruiz J; Vilacosta I; Montejo M; Vallejo N; López-Medrano F; Plata A; López J; Hidalgo-Tenorio C; Gálvez J; Sáez C; Lomas JM; Falcone M; de la Torre J; Martínez-Lacasa X; Pahissa A Clin Infect Dis; 2013 May; 56(9):1261-8. PubMed ID: 23392394 [TBL] [Abstract][Full Text] [Related]
3. Editorial Commentary: Enterococcus faecalis infective endocarditis: is it time to abandon aminoglycosides? Munita JM; Arias CA; Murray BE Clin Infect Dis; 2013 May; 56(9):1269-72. PubMed ID: 23392395 [No Abstract] [Full Text] [Related]
7. Reply to Gelfand et al and Solla. Fernández-Hidalgo N; Almirante B; Pahissa A Clin Infect Dis; 2013 Sep; 57(5):768-70. PubMed ID: 23704124 [No Abstract] [Full Text] [Related]
8. Changes in the treatment of Enterococcus faecalis infective endocarditis in Spain in the last 15 years: from ampicillin plus gentamicin to ampicillin plus ceftriaxone. Pericas JM; Cervera C; del Rio A; Moreno A; Garcia de la Maria C; Almela M; Falces C; Ninot S; Castañeda X; Armero Y; Soy D; Gatell JM; Marco F; Mestres CA; Miro JM; Clin Microbiol Infect; 2014 Dec; 20(12):O1075-83. PubMed ID: 25040215 [TBL] [Abstract][Full Text] [Related]
9. Success of ampicillin plus ceftriaxone rescue therapy for a relapse of Enterococcus faecalis native-valve endocarditis and in vitro data on double beta-lactam activity. Miro JM; Cervera C; Garcia-de-la-Maria C; Del Rio A; Armero Y; Mestres CA; Grau JM; Marco F; Moreno A Scand J Infect Dis; 2008; 40(11-12):968-72. PubMed ID: 18767002 [TBL] [Abstract][Full Text] [Related]
10. Efficacy of the combination ampicillin plus ceftriaxone in the treatment of a case of enterococcal endocarditis due to Enterococcus faecalis highly resistant to gentamicin: efficacy of the "ex vivo" synergism method. Tascini C; Doria R; Leonildi A; Martinelli C; Menichetti F J Chemother; 2004 Aug; 16(4):400-3. PubMed ID: 15332717 [TBL] [Abstract][Full Text] [Related]
11. Comparison of Dual β-Lactam therapy to penicillin-aminoglycoside combination in treatment of Enterococcus faecalis infective endocarditis. El Rafei A; DeSimone DC; Narichania AD; Sohail MR; Vikram HR; Li Z; Steckelberg JM; Wilson WR; Baddour LM J Infect; 2018 Nov; 77(5):398-404. PubMed ID: 29969596 [TBL] [Abstract][Full Text] [Related]
12. Combination of Ceftriaxone and Ampicillin for the Treatment of Enterococcal Endocarditis: A Qualitative Systematic Review. Peterson SC; Lau TTY; Ensom MHH Ann Pharmacother; 2017 Jun; 51(6):496-503. PubMed ID: 28166656 [TBL] [Abstract][Full Text] [Related]
13. Time to abandon ampicillin plus gentamicin in favour of ampicillin plus ceftriaxone in Enterococcus faecalis infective endocarditis? A meta-analysis of comparative trials. Mirna M; Topf A; Schmutzler L; Hoppe UC; Lichtenauer M Clin Res Cardiol; 2022 Oct; 111(10):1077-1086. PubMed ID: 34751788 [TBL] [Abstract][Full Text] [Related]
14. Which trial do we need? Aminopenicillin-gentamicin versus aminopenicillin-ceftriaxone for Enterococcus faecalis endocarditis. Luque-Paz D; Cuervo G; Miró JM; Tattevin P Clin Microbiol Infect; 2023 Jun; 29(6):676-678. PubMed ID: 36889644 [No Abstract] [Full Text] [Related]
15. In vitro synergism and anti-biofilm activity of ampicillin, gentamicin, ceftaroline and ceftriaxone against Enterococcus faecalis. Thieme L; Klinger-Strobel M; Hartung A; Stein C; Makarewicz O; Pletz MW J Antimicrob Chemother; 2018 Jun; 73(6):1553-1561. PubMed ID: 29506271 [TBL] [Abstract][Full Text] [Related]
16. Early in vitro development of daptomycin non-susceptibility in high-level aminoglycoside-resistant Enterococcus faecalis predicts the efficacy of the combination of high-dose daptomycin plus ampicillin in an in vivo model of experimental endocarditis. Pericàs JM; García-de-la-Mària C; Brunet M; Armero Y; García-González J; Casals G; Almela M; Quintana E; Falces C; Ninot S; Fuster D; Llopis J; Marco F; Moreno A; Miró JM; J Antimicrob Chemother; 2017 Jun; 72(6):1714-1722. PubMed ID: 28204495 [TBL] [Abstract][Full Text] [Related]
17. Efficacy of ampicillin combined with ceftriaxone and gentamicin in the treatment of experimental endocarditis due to Enterococcus faecalis with no high-level resistance to aminoglycosides. Gavaldá J; Onrubia PL; Gómez MT; Gomis X; Ramírez JL; Len O; Rodríguez D; Crespo M; Ruíz I; Pahissa A J Antimicrob Chemother; 2003 Sep; 52(3):514-7. PubMed ID: 12917251 [TBL] [Abstract][Full Text] [Related]
18. Once-daily aminoglycoside in the treatment of Enterococcus faecalis endocarditis: case report and review. Tam VH; Mckinnon PS; Levine DP; Brandel SM; Rybak MJ Pharmacotherapy; 2000 Sep; 20(9):1116-9. PubMed ID: 10999505 [TBL] [Abstract][Full Text] [Related]
19. Four weeks versus six weeks of ampicillin plus ceftriaxone in Enterococcus faecalis native valve endocarditis: A prospective cohort study. Ramos-Martínez A; Pericàs JM; Fernández-Cruz A; Muñoz P; Valerio M; Kestler M; Montejo M; Fariñas MC; Sousa D; Domínguez F; Ojeda-Burgos G; Plata A; Vidal L; Miró JM; PLoS One; 2020; 15(8):e0237011. PubMed ID: 32745091 [TBL] [Abstract][Full Text] [Related]